Znn3bq.jpeg
±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 640  |  »Ø¸´: 9
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

shawne2008

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ÕªÒª·­Òë

Downstream Antibody Purification using Aqueous Two-Phase Extraction

The extraction of antibodies using a polyethyleneglycol(PEG)-citrate aqueous two-phase system(ATPS) was in vestigated.Studies using purified monoclonal antibody(mAb) identified operating ranges for successful phase formation and factors that significantly affected antibody partitioning. The separation of antibody and host cel lprotein(HCP) from clarified cell culture media was examined using statistical design of experiments(DOE). The partitioning of antibody was nearly complete over the entire range of the operating space examined.A model of the HCP partitioning was generated in which both NaCl and citrate concentrations were identified assignificant factors.To achieve the highest purity,the partitioning of HCP
from cell culture fluid into the product containing phase was minimized using a Steepest Descent algorithm.An optimal ATPS consisting of 14.0%(w/w) PEG,8.4%(w/w)citrate,and7.2%(w/w)NaCl at pH7.2 resulted in a product yield of 89%,anapproximate 7.6- fold reduction in HCP levels relative to the clarified cell culture fluid before extraction and an overall purity of 70%.A system consisting of 15%(w/w)PEG,8%(w/w)citrate,and15% (w/w) NaCl at pH5.5 reduced product-related impurities(aggregates and low molecular product fragments)from 40% to less than0.5%while achieving 95% product recovery.At the experimental conditions that were optimized in the batch mode,a scale-up model for the use of counter-current extraction technology was developed to identify potential improvements in purity and recovery tha tcould be realized in the continuous operational mode

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Studies using purified monoclonal antibody(mAb) identified operating ranges for successful phase formation and factors that significantly affected antibody partitioning. Ñо¿Ê¹Óô¿»¯µ¥¿Ë¡¿¹Ì壨mAb£©Ê¶±ð²Ù×÷°üÀ¨ÏàµÄ³É¹¦ÐγɺÍÓ°Ï쿹Ìå·ÖÀëµÄÒòËØ
4Â¥2011-03-13 15:59:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð
shawne2008(½ð±Ò+120, ·­ÒëEPI+1): Ò»ÆðÆÀÁ˰ɣ¬ÕûÌåÉÏ»¹ÊDZȽÏÂúÒâµÄ£¬µ«ÊDz¿·Ö»¹ÊDz»¹»×¼È·£¬¸ÐлӦÖú 2011-03-13 21:51:57
Downstream Antibody Purification using Aqueous Two-Phase Extraction
ÀûÓÃË®ÈÜÒºÁ½ÏàÝÍÈ¡µÄ·½·¨¶ÔÏÂÓο¹ÌåµÄ´¿»¯
2Â¥2011-03-13 15:53:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
The extraction of antibodies using a polyethyleneglycol(PEG)-citrate aqueous two-phase system() was in vestigated.

Ñо¿ÁËÓþÛÒÒ¶þ´¼£¨PEG£©-ÄûÃÊËá˫ˮÏàÌåϵ£¨ATPS£©ÌáÈ¡¿¹Ìå
3Â¥2011-03-13 15:55:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
The separation of antibody and host cel lprotein(HCP) from clarified cell culture media was examined using statistical design of experiments(DOE).ʹÓÃʵÑ飨DOE£©µÄͳ¼ÆÉè¼Æ¶Ô´Ó·ÖÀëϸ°ûÅàÑø»ùÉϵõ½µÄ¿¹ÌåºÍËÞÖ÷ϸ°ûµ°°×ÖÊ(HCP)½øÐмì²â¡£
5Â¥2011-03-13 16:06:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 275Çóµ÷¼Á +4 1624447980 2026-04-08 5/250 2026-04-08 15:29 by ŶŶ123
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÄÏʦ·¶´óѧ0702ÎïÀíѧ305µ÷¼Á +3 Äî³£°² 2026-04-07 5/250 2026-04-08 06:45 by lijunpoly
[¿¼ÑÐ] 277¡¢Ñ§Ë¶£¬Çóµ÷¼Á ÊýÒ»104£¬ +11 Æ¿×ÓPZ 2026-04-07 12/600 2026-04-07 23:30 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϿƴóÉúÎïѧ297·Ö£¬Çóµ÷¼ÁÍÆ¼ö +8 Y-yyusx 2026-04-06 9/450 2026-04-07 19:38 by biomichael
[¿¼ÑÐ] ÉúÎïµ÷¼Á +5 ³È×Ó³È×Ó³È×Ó°¡ 2026-04-05 9/450 2026-04-07 15:31 by Éϰ¶¿ì¿ì
[¿¼ÑÐ] 081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ +19 ÅûÐÇºÓ 2026-04-03 19/950 2026-04-07 15:14 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 081700£¬311£¬Çóµ÷¼Á +17 ¶¬Ê®Èý 2026-04-04 18/900 2026-04-07 12:50 by Sammy2
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ0710£¨A£©³õÊÔ329·Ö Çóµ÷¼Á +5 Ò»Ãû26¿¼ÑÐÉú 2026-04-04 5/250 2026-04-07 08:54 by 18828373951
[¿¼ÑÐ] 318Çóµ÷¼Á +12 ykyhsa 2026-04-05 14/700 2026-04-06 17:46 by fuyu_
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +5 ´Þwj 2026-04-05 5/250 2026-04-06 15:40 by lin-da
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-05 4/200 2026-04-06 12:29 by ÖзÉÔº¿Õ¹ÜѧԺÑ
[¿¼ÑÐ] 0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319 +14 lv945 2026-04-04 14/700 2026-04-06 10:20 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÔõôɾÌû×Ó°¡ +3 ·ìêØ1000 2026-04-04 3/150 2026-04-04 14:20 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Çóµ÷¼Á +8 akdhjs 2026-04-03 8/400 2026-04-03 18:17 by ´÷άING
[¿¼ÑÐ] ¹¤¿Æ 267Çóµ÷¼Á +5 wanwan00 2026-04-02 7/350 2026-04-03 14:14 by zhangdingwa
[¿¼ÑÐ] ÊýÒ»Ó¢Ò»285Çóµ÷¼Á +7 AZMK 2026-04-03 9/450 2026-04-03 13:03 by ms629
[¿¼ÑÐ] 330Çóµ÷¼Á +3 °×ÉñÎØºôºô 2026-04-02 3/150 2026-04-03 10:15 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 274Çóµ÷¼Á +10 Ѧ¶¨Ú̵Ļ¢¡£ 2026-04-01 10/500 2026-04-03 10:13 by tianyyysss
[¿¼ÑÐ] 309Çóµ÷¼Á +14 ´ô¹½²»ÊÇ´÷·ò 2026-04-02 14/700 2026-04-03 09:42 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 260Çóµ÷¼Á +3 ÖìÜÆÁÕ 2026-04-02 3/150 2026-04-03 08:44 by yulian1987
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û